MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Intercept Pharmaceuticals Company Profile (NASDAQ:ICPT)

Consensus Ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) (?)
Ratings Breakdown: 2 Sell Rating(s), 3 Hold Rating(s), 13 Buy Rating(s)
Consensus Rating:Buy (Score: 2.61)
Consensus Price Target: $367.13 (92.78% upside)

Current Analysts' Coverage Summary for Intercept Pharmaceuticals (NASDAQ:ICPT)
Show:
DateFirmActionRatingPrice TargetActions
8/31/2015WedbushReiterated RatingBuy$493.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015Morgan StanleyInitiated CoverageUnderweight$165.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015Needham & Company LLCInitiated CoverageBuy$500.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015Janney Montgomery ScottReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Cowen and CompanyReiterated RatingBuy$420.00 -> $412.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015RBC CapitalReiterated RatingOutperform$490.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/3/2015OppenheimerReiterated RatingOutperform$375.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2015MLV & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2015Robert W. BairdReiterated RatingBuy$344.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/21/2015BarclaysInitiated CoverageOverweight$425.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015BMO Capital MarketsSet Price TargetBuy$515.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015Bank of AmericaDowngradeBuy -> Neutral$315.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Deutsche BankBoost Price TargetBuy$300.00 -> $400.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Leerink SwannBoost Price TargetMarket Perform$205.00 -> $265.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2015NomuraSet Price TargetBuy$440.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2014Sterne Agee CRTInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2014FBR & Co.Lower Price TargetUnderperform$125.00 -> $99.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2014Summer StreetReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2014Goldman SachsInitiated CoverageNeutral$265.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/10/2014Citigroup Inc.Reiterated RatingBuy$60.00 -> $400.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/3/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha